Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia
Clinical trial NCT05057221 · TERMINATED
Trial details
- NCT number
- NCT05057221
- Sponsor
- Lena Napolitano, MD
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-12
- Primary completion
- 2022-03-09
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.